Tina Ken Schramm

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

Morten Lock Hansen, Rikke Sørensen, Mette T. Clausen et al. · Archives of Internal Medicine · 2010 · 846 citations

Medicine, Cardiology, Pharmacotherapy +17

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

Tina Ken Schramm, Gunnar Gislason, Lars Køber et al. · Circulation · 2008 · 541 citations

Medicine, Cardiology, Internal Medicine +12

Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

Gunnar Gislason, Søren Jacobsen, Jeppe Nørgaard Rasmussen et al. · Circulation · 2006 · 452 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

Tina Ken Schramm, Gunnar Gislason, Allan Vaag et al. · European Heart Journal · 2011 · 418 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure

Gunnar Gislason, Jeppe Nørgaard Rasmussen, Steen Z. Abildstrøm et al. · Archives of Internal Medicine · 2009 · 294 citations

Medicine, Cardiology, Pharmacotherapy +13